Latest Breaking News On - Hedge funds weigh in on corbus pharmaceuticals - Page 1 : comparemela.com

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 403,800 shares, a growth of 560.9% from the February 29th total of 61,100 shares. Based on an average daily volume of 886,400 […]

Corbus pharmaceuticalsInsider activity at corbus pharmaceuticalsHedge funds weigh in on corbus pharmaceuticalsBlackrock incCorbus pharmaceuticals price performanceCorbus pharmaceuticals holdings incNews ratings for corbus pharmaceuticals dailyRenaissance technologiesJefferies financial groupVident investment advisoryCorbus pharmaceuticals holdingsGet free reportFinancial groupCormorant asset managementSigma investmentsStreet corp